Snider Financial Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.04M | Hold |
24,000
| – | – | 0.88% | 33 |
|
|
2025
Q1 | $3.07M | Hold |
24,000
| – | – | 1% | 32 |
|
|
2024
Q4 | $3.17M | Hold |
24,000
| – | – | 0.98% | 32 |
|
|
2024
Q3 | $3.49M | Buy |
24,000
+3,970
| +20% | +$578K | 1.28% | 28 |
|
|
2024
Q2 | $2.75M | Hold |
20,030
| – | – | 1.06% | 33 |
|
|
2024
Q1 | $2.75M | Buy |
20,030
+5,030
| +34% | +$690K | 1.15% | 28 |
|
|
2023
Q4 | $2.04M | Hold |
15,000
| – | – | 0.94% | 34 |
|
|
2023
Q3 | $1.83M | Hold |
15,000
| – | – | 0.89% | 36 |
|
|
2023
Q2 | $1.9M | Buy |
+15,000
| New | +$1.9M | 0.91% | 34 |
|
|
2023
Q1 | – | Sell |
-5,157
| Closed | -$677K | – | 56 |
|
|
2022
Q4 | $677K | Hold |
5,157
| – | – | 0.37% | 42 |
|
|
2022
Q3 | $633K | Hold |
5,157
| – | – | 0.34% | 41 |
|
|
2022
Q2 | $607K | Hold |
5,157
| – | – | 0.33% | 39 |
|
|
2022
Q1 | $672K | Hold |
5,157
| – | – | 0.31% | 38 |
|
|
2021
Q4 | $786K | Hold |
5,157
| – | – | 0.33% | 40 |
|
|
2021
Q3 | $823K | Hold |
5,157
| – | – | 0.36% | 41 |
|
|
2021
Q2 | $829K | Buy |
+5,157
| New | +$829K | 0.39% | 40 |
|